Willis-Knighton Health System in Shreveport, La., partnered with Johnson & Johnson Medical Device Companies.
"As the market adopts more and more alternative payment models like orthopedic bundled payment programs, improving patient outcomes while driving costs down is vital to maintaining Willis-Knighton's status as one of the country's leading health systems," said Chris Magnin, physical medicine director of Willis-Knighton Health System.
Here are five key notes:
1. The company announced CareAdvantage in conjunction with the Orthopaedic Episode of Care Approach. CareAdvantage is designed to provide a "holistic approach" to helping providers deliver better care.
2. Johnson & Johnson will offer the Orthopaedic Episode of Care Approach under their CareAdvantage capabilities. The alternative care models could include CMS's Comprehensive Care for Joint Replacement and the Surgical Hip and Femur Fracture Treatment models, measuring episodes of care.
3. The Orthopaedic Episode of Care option includes a shared performance agreement option to help reduce average episodic hip and knee implant patient costs.
4. The platform aims to support hospitals and health systems for the 90 day episodes of care for knee, hip and shoulder implants.
5. The Orthopaedic Episode of Care includes these CareAdvantage capabilities:
• Episode Performance Improvement supported by Value Stream Partners.
• Infection Risk Management that provides evidence-based practices to address blood stream infections and surgical site infection risk factors.
• Hip Fracture Care, an evidence-based care improvement program designed to standardize care.
• Digital Care Navigation, a cloud-based platform from CareSense, provided by MedTrak.
• Patient Athlete, which uses science-based principles from the Johnson & Jonson Human Performance Institute to prepare for and recover from orthopedic surgery.
More articles on orthopedic devices:
US implantable device market to reach $73.9B in 2018: 6 observations
SpineGuard hits FY 2016 revenue of $7.95M—5 key notes
Titan Medical names David McNally new CEO—7 key points